The symptoms of rosacea predominantly appear on the face and are difficult to conceal, often having a significant psychosocial impact on the lives of patients. A recent study conducted by the National Rosacea Society (NRS) involving 1,235 patients reported that 68% of the respondents felt a decrease in their self-esteem and confidence following the onset of their rosacea. Approximately 55% said they were embarrassed by this condition and an equal number expressed feelings of frustration. 30% felt helpless in the face of the disease, 25% reported feeling anxious and 20% had been depressed due to their rosacea. Finally, 43% reported that their outlook on life had been negatively affected by their rosacea. Furthermore, another study showed that patients were willing to pay an average of €2,880 to be completely cured, with the amount correlating to the deterioration in quality of life.
Furthermore, numerous cases of erythrophobia are recorded among individuals with somatic causes of blushing, such as rosacea. Erythrophobia is an anxiety disorder classified within the family of social phobias and is characterised by the fear of blushing in public. Those who blush easily do not wish to show others that they are affected by certain topics as they interpret this as a form of weakness. However, patients have no control over the onset of redness. This can indeed occur following a simple physical effort or under the influence of an emotion. A vicious cycle then sets in: the person worries about their next rosacea flare-ups while this emotional state promotes the appearance of symptoms.
This disease can thus be a hindrance in social life of the affected individuals. During periods when the symptoms are most visible, many patients tend to avoid social outings or family moments, for fear of stares and judgements, or simply because of their discomfort. Finally, rosacea also has a impact in the professional sphere, confirmed by a recent study conducted in various countries around the world (United Kingdom, France, Germany, Italy, Mexico, Switzerland, Denmark, Ireland). This showed that people suffering from erythrosis were nearly twice as less likely to be hired than others.